Abstract:OBJECTIVE: It has been reported that there are differences between in vitro and in vivo matured oocytes for their survival rates following vitrification The purpose of this study is to determine the competency of cryodamage resistance of in vitro matured oocytes in the presence of cysteamine during in vitro maturation (IVM).DESIGN: Animal-model study.MATERIALS AND METHODS: Female mice (CD-1) were stimulated with 10IU PMSG. Oocytes were collected after 48h and the collected oocytes were divided into following groups: (1) Cumulus-oocyte-complex (COC); (2) denuded groups. Both COC and denuded oocytes were cultured in IVM medium containing 75mIU/mL FSH and LH, 10% FBS for 16 h in the presence or absence of cysteamine (200μM). Following culture, the maturated oocytes were either vitrified or inseminated immediately. Vitrification and thawing procedures were performed with McGill Cryoleaf as reported previously. Vitrified oocytes were thawed and inseminated on the other day. Fertilization rate were recorded 24 h after insemination, and early embryonic development were assessed. Statistical differences were considered significant at p<0.05.RESULTS: The presence of cysteamine during IVM significantly increased maturation rate in COC group but had no significant difference in denuded group. The presence of cyseamine during IVM does not improve the survival rate of in vitro matured oocytes with or without cumulus cells during IVM. However, the presence of cumulus cells during IVM had better fertilization rate (p<0.05) compared to the denuded oocytes after vitrification-thawing. The presence of cysteamine during IVM significantly reduced the fragmentation rate in cumulus-intact group compared to cumulus-free group following vitrification-thawing.CONCLUSIONS: The presence of cysteamine during IVM has beneficial effect on both COC and denuded oocytes in terms of their competency of subsequent fertilization and early embryonic development following vitrification. OBJECTIVE: It has been reported that there are differences between in vitro and in vivo matured oocytes for their survival rates following vitrification The purpose of this study is to determine the competency of cryodamage resistance of in vitro matured oocytes in the presence of cysteamine during in vitro maturation (IVM). DESIGN: Animal-model study. MATERIALS AND METHODS: Female mice (CD-1) were stimulated with 10IU PMSG. Oocytes were collected after 48h and the collected oocytes were divided into following groups: (1) Cumulus-oocyte-complex (COC); (2) denuded groups. Both COC and denuded oocytes were cultured in IVM medium containing 75mIU/mL FSH and LH, 10% FBS for 16 h in the presence or absence of cysteamine (200μM). Following culture, the maturated oocytes were either vitrified or inseminated immediately. Vitrification and thawing procedures were performed with McGill Cryoleaf as reported previously. Vitrified oocytes were thawed and inseminated on the other day. Fertilization rate were recorded 24 h after insemination, and early embryonic development were assessed. Statistical differences were considered significant at p<0.05. RESULTS: The presence of cysteamine during IVM significantly increased maturation rate in COC group but had no significant difference in denuded group. The presence of cyseamine during IVM does not improve the survival rate of in vitro matured oocytes with or without cumulus cells during IVM. However, the presence of cumulus cells during IVM had better fertilization rate (p<0.05) compared to the denuded oocytes after vitrification-thawing. The presence of cysteamine during IVM significantly reduced the fragmentation rate in cumulus-intact group compared to cumulus-free group following vitrification-thawing. CONCLUSIONS: The presence of cysteamine during IVM has beneficial effect on both COC and denuded oocytes in terms of their competency of subsequent fertilization and early embryonic development following vitrification.

Human oocyte vitrification with corona radiata, in autologous follicular fluid supplemented with ethylene glycol, preserves conventional IVF potential: birth of four healthy babies.

Clinical application of vitrification freezing of oocytes

The Effect of Antioxidant Agent During in Vitro Maturation (IVM) of Murine Oocytes on Survival, Fertilization and Early Embryonic Development Following Vitrification

The clinical outcome of human oocytes vitrification in infertility couples

Vitrification of oocytes for in vitro fertilization and embryo transfer]

Fertilization rates are improved after IVF if the corona radiata is left intact in vitrified-warmed human oocytes.

An Eight Year Experience of Autologous Oocyte Vitrification for Infertile Patients Owing to Unavailability of Sperm on Oocyte Retrieval Day

A Modified Vitrification Method Reduces Spindle and Chromosome Abnormalities

Efficiency and safety of vitrification of surplus oocytes following superovulation: a comparison of different clinical indications of oocyte cryopreservation in IVF/ICSI cycles

[Effects of Cryopreservation Time and Thawing Method of Human Oocyte Vitrification on the Outcome of Assisted Reproduction].

Vitrification Yields Superior Efficiency of Human Cleavage-Stage Embryo Cryopreservation Versus Slow-Freezing

[Clinical Application of Oocyte Vitrification in Failed Testicular Sperm Extraction Cycles: Report of 8 Cases].

[In Vitro Maturation--n Vitro Fertilization--embryo Transfer--frozen-thawed of Human Oocytes].

Effects of Trehalose Vitrification and Artificial Oocyte Activation on the Development Competence of Human Immature Oocytes.

Human follicular fluid and mesenchymal stem cell conditioned medium improves in vitro development of vitrified-warmed mouse oocytes

Research on the In Vitro Maturation and Vitrification of Oocytes from Human Luteal Phase

Effects of vitrification on the development potential and transcriptome of human oocyte matured in vitro

Effects of Cumulus Cells on Vitreous Cryopreservation of Human Mature Oocytes and Clinical Pregnancy Outcomes

Improved Cryotolerance and Developmental Competence of Human Oocytes Matured in Vitro by Transient Hydrostatic Pressure Treatment Prior to Vitrification.

Effects of Vitrification on the Development of Mouse GV-oocytes

Oocytes Vitrification Using Automated Equipment Based on Microfluidic Chip